messag updat estim
follow recent report result reiter pt
rais pt remov pt rais
pt remov pt remov
pt
tweak revenue/adjust ebitda estim
previous introduc estim updat estim
reflect impact result revis outlook remaind
tweak revenue/adjust ebitda estim
 previous updat estim reflect
impact result revis outlook remaind
tweak revenue/adjust ebitda estim
 previous updat estim reflect
impact result revis outlook remaind
tweak revenue/adjust ebitda estim
 previous updat estim reflect impact
result revis outlook remaind
tweak revenue/adjust ebitda estim
 previous updat estim reflect
impact result revis outlook remaind
tweak revenue/adjust ebitda estim
 previous updat estim
reflect impact result revis outlook remaind
page analyst certif import disclosur
valuat risk
reiter price target base ev/ebitda roughli line previou target
multipl valuat repres premium broader suppli chain trade view warrant given
healthier trend core busi also repres discount five-year histor averag view
warrant given structur concern around industri opioid overhang primari risk downsid
less favor trend brand gener price anoth risk downsid regulatori reform could neg impact industri
econom maintain buy rate
rais price target base ev/ebitda higher target multipl vs
previous reflect improv industri fundament target valuat rel line averag multipl
believ warrant given improv industri fundament given price target impli potenti upsid
current level reiter buy rate believ biggest risk downsid pend opioid litig particularli
given uncertainti around potenti size time settlement fine addit note risk less favor brand
gener price trend
valu ev/ebitda basi believ appropri metric comparison across matur
hcit peer reiter neutral rate remov pt key risk downsid potenti regulatori reform
neg impact compani busi model custom base anoth risk downsid potenti intensifi
competit payment integr space due consolid competitor key risk upsid potenti better
expect oper leverag due busi mix compani technolog invest anoth risk upsid potenti
acceler market penetr compani popul health manag busi
rais price target base ev/ebitda valuat gener
slight discount five-year histor averag believ warrant given structur concern around
busi primari risk downsid potenti lower end-market demand consum equip impact
growth rate anoth risk downsid potenti custom consolid greater competit neg impact price
valu ev/revenu basi similar high growth hcit peer maintain neutral rate
remov pt risk downsid potenti lower anticip end-market demand support compani financi
target anoth risk downsid potenti medic safeti solut fall client invest prioriti risk
upsid potenti acceler progress compani cross-sel initi anoth risk upsid potenti
acceler margin improv compani mix servic busi increas
valu ev/ebitda basi similar matur dental peer maintain neutral rate remov
pt primari risk upsid acceler progress compani margin expans initi addit risk
upsid potenti acceler improv end-market demand primari risk downsid potenti intern
restructur neg impact execut moreov downsid risk gener econom slowdown impact dental industri
page analyst certif import disclosur
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
equiti valuat risk valuat methodolog risk associ cover compani price target cover compani pleas
see recent company-specif research report http //guggenheimlibrari bluematrix com/client/librari jsp contact primari analyst
guggenheim secur llc repres email
research client prospect client disclosur relat guggenheim secur affili research
